Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1203
| Despition | ADCY8 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
| ACPP-1009 | Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) | 50 µg | inquiry |
| ACPP-1010 | Synthetic Nanodisc Human GPR56 Protein (AC1010) | 10 µg | inquiry |
| ACPP-1541 | Human OTOR Protein (AC1541) | 5 µg | inquiry |
| ACPP-1008 | Recombinant Human Siglec 7 Protein (6×His Tag) (AC1008) | 50 µg | inquiry |
| ACPP-1818 | Mouse FGF 9 Protein (AC1818) | 2 µg | inquiry |
| ACPP-1820 | Rat CNTF Protein, His (AC1820) | 2 µg | inquiry |
| ACPP-1046 | Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) | 50 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
| ACPP-1299 | Calretinin Blocking Peptide (AC1299) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.